Profile | GDS4284 / 238525_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 571.539 | 66 |
GSM687648 | Patient 402 control | 339.307 | 58 |
GSM687653 | Patient 403 control | 861.366 | 72 |
GSM687658 | Patient 404 control | 757.012 | 70 |
GSM687663 | Patient 411 control | 869.344 | 72 |
GSM687668 | Patient 422 control | 701.221 | 69 |
GSM687673 | Patient 424 control | 830.449 | 71 |
GSM687678 | Patient 425 control | 841.295 | 71 |
GSM687683 | Patient 427 control | 1034.78 | 74 |
GSM687688 | Patient 428 control | 890.001 | 72 |
GSM687695 | Patient 441 control | 313.934 | 50 |
GSM687699 | Patient 443 control | 1159.82 | 76 |
GSM687704 | Patient 444 control | 1373.43 | 79 |
GSM687707 | Patient 448 control | 993.283 | 74 |
GSM687712 | Patient 449 control | 774.85 | 70 |
GSM687719 | Patient 450 control | 710.508 | 68 |
GSM687724 | Patient 451 control | 933.558 | 73 |
GSM687728 | Patient 452 control | 672.315 | 68 |
GSM687646 | Patient 401 treated 24h | 661.772 | 67 |
GSM687649 | Patient 402 treated 24h | 297.421 | 56 |
GSM687665 | Patient 411 treated 24h | 738.545 | 69 |
GSM687651 | Patient 402 treated 4 weeks | 585.701 | 65 |
GSM687667 | Patient 411 treated 4 weeks | 689.289 | 68 |
GSM687670 | Patient 422 treated 24h | 1012.3 | 74 |
GSM687671 | Patient 422 treated 4 weeks | 999.932 | 74 |
GSM687654 | Patient 403 treated 24h | 952.039 | 74 |
GSM687675 | Patient 424 treated 24h | 608.058 | 66 |
GSM687685 | Patient 427 treated 24h | 895.115 | 72 |
GSM687656 | Patient 403 treated 4 weeks | 645.084 | 68 |
GSM687677 | Patient 424 treated 4 weeks | 1239.76 | 77 |
GSM687687 | Patient 427 treated 4 weeks | 553.031 | 65 |
GSM687692 | Patient 428 treated 4h | 1336.97 | 78 |
GSM687716 | Patient 449 treated 4h | 813.924 | 71 |
GSM687722 | Patient 450 treated 4h | 364.319 | 57 |
GSM687680 | Patient 425 treated 24h | 833.323 | 71 |
GSM687690 | Patient 428 treated 24h | 554.357 | 66 |
GSM687700 | Patient 443 treated 24h | 560.376 | 63 |
GSM687705 | Patient 444 treated 24h | 1714.79 | 82 |
GSM687714 | Patient 449 treated 24h | 599.839 | 67 |
GSM687721 | Patient 450 treated 24h | 383.732 | 57 |
GSM687682 | Patient 425 treated 4 weeks | 656.185 | 68 |
GSM687694 | Patient 428 treated 4 weeks | 955.412 | 73 |
GSM687702 | Patient 443 treated 4 weeks | 1005.4 | 74 |
GSM687718 | Patient 449 treated 4 weeks | 883.986 | 73 |
GSM687723 | Patient 450 treated 4 weeks | 603.855 | 66 |
GSM687661 | Patient 404 treated 4h | 677.385 | 68 |
GSM687710 | Patient 448 treated 4h | 881.462 | 73 |
GSM687726 | Patient 451 treated 4h | 1192.12 | 77 |
GSM687730 | Patient 452 treated 4h | 275.822 | 39 |
GSM687660 | Patient 404 treated 24h | 271.754 | 51 |
GSM687697 | Patient 441 treated 24h | 322.838 | 53 |
GSM687709 | Patient 448 treated 24h | 802.497 | 71 |
GSM687725 | Patient 451 treated 24h | 697.633 | 68 |
GSM687729 | Patient 452 treated 24h | 333.128 | 54 |
GSM687727 | Patient 451 treated 4 weeks | 1746 | 82 |
GSM687731 | Patient 452 treated 4 weeks | 663.431 | 68 |